Squarepoint
IRON icon

Squarepoint’s Disc Medicine IRON Stock Holding History

Squarepoint’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.55M Buy
75,872
+44,163
+139% +$3.03M 0.01% 1526
2026
Q1 		$2.03M Buy
31,709
+15,955
+101% +$1.11M ﹤0.01% 2171
2025
Q4 		$1.25M Buy
15,754
+10,377
+193% +$877K ﹤0.01% 2418
2025
Q3 		$355K Buy
+5,377
New +$320K ﹤0.01% 3535
2024
Q4 		– Sell
-8,805
Closed -$509K – 5267
2024
Q3 		$433K Buy
+8,805
New +$413K ﹤0.01% 3207
2024
Q1 		– Sell
-8,107
Closed -$468K – 4286
2023
Q4 		$468K Buy
8,107
+2,907
+56% +$149K ﹤0.01% 3055
2023
Q3 		$244K Buy
+5,200
New +$260K ﹤0.01% 3292
2022
Q1 		– Sell
-494
Closed -$43K – 3175
2021
Q4 		$43K Buy
+494
New +$48.4K ﹤0.01% 3042

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Squarepoint's IRON Position: Q2 2026 in Review

Squarepoint increased its Disc Medicine (IRON) stake by 139% in Q2 2026, buying an estimated $3.03M and bringing the position to 75,872 shares worth $5.55M. The position accounts for 0.01% of the portfolio, ranked #1526.

Squarepoint first reported a position in IRON in Q4 2021 and has held it in 8 quarters since. 217 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Squarepoint held 75,872 shares of Disc Medicine worth $5.55M as of Q2 2026.
  • Squarepoint bought 44,163 Disc Medicine shares in Q2 2026, an estimated $3.03M.
  • Disc Medicine made up 0.01% of Squarepoint's portfolio in Q2 2026, its #1526 holding.
  • Squarepoint first reported a position in Disc Medicine in Q4 2021 and has held it in 8 quarters since.
  • 217 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.